HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Inoue Selected Research

p-Chloroamphetamine

10/2001Effects of the 5-HT2 receptor antagonist, ritanserin on hyperthermia and depletion of 5-HT in frontal cortex induced by a 5-HT releasing drug, p-chloroamphetamine (PCA) in mice.
8/2001Role of 5-HT(2) receptor subtypes in depletion of 5-HT induced by p-chloroamphetamine in the mouse frontal cortex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Inoue Research Topics

Disease

58Neoplasms (Cancer)
01/2022 - 01/2000
20Neoplasm Metastasis (Metastasis)
01/2021 - 01/2000
10Inflammation (Inflammations)
11/2008 - 04/2000
10Urinary Bladder Neoplasms (Bladder Cancer)
01/2008 - 04/2000
10Hepatocellular Carcinoma (Hepatoma)
08/2001 - 01/2000
9Breast Neoplasms (Breast Cancer)
01/2021 - 01/2000
9Carcinoma (Carcinomatosis)
12/2014 - 01/2000
9Stomach Neoplasms (Stomach Cancer)
10/2013 - 03/2000
9Lung Neoplasms (Lung Cancer)
01/2008 - 04/2000
8Transitional Cell Carcinoma
09/2001 - 04/2000
7Pain (Aches)
03/2020 - 04/2000
7Carcinogenesis
07/2001 - 01/2000
6Rheumatoid Arthritis
02/2008 - 07/2000
6Lymphatic Metastasis
01/2008 - 05/2000
6Prostatic Neoplasms (Prostate Cancer)
12/2001 - 04/2000
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2022 - 07/2000
5Pneumonia (Pneumonitis)
04/2009 - 01/2007
5Chronic Hepatitis C
01/2009 - 09/2000
5Infections
01/2009 - 03/2000
5Renal Cell Carcinoma (Grawitz Tumor)
10/2001 - 09/2000
4Disease Progression
01/2021 - 08/2000
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 01/2005
4Hyperalgesia
01/2013 - 08/2000
4Necrosis
10/2009 - 04/2000
4Lung Injury
07/2008 - 07/2003
4Edema (Dropsy)
04/2008 - 06/2000
4Arthritis (Polyarthritis)
11/2007 - 03/2000
4Thrombosis (Thrombus)
01/2005 - 05/2000
4Diabetes Mellitus
01/2005 - 01/2001
4Pelizaeus-Merzbacher Disease
01/2002 - 01/2001
4Motor Neuron Disease (Primary Lateral Sclerosis)
03/2001 - 05/2000
3Vomiting
03/2020 - 11/2001
3Asthma (Bronchial Asthma)
11/2017 - 06/2001
3Body Weight (Weight, Body)
04/2015 - 10/2000
3Massive Hepatic Necrosis
12/2010 - 11/2000
3Wounds and Injuries (Trauma)
12/2009 - 07/2007
3Hemorrhage
05/2008 - 07/2001
3Fever (Fevers)
02/2007 - 06/2000
3Osteoarthritis
03/2004 - 01/2000
3Mitochondrial Diseases (Mitochondrial Disease)
11/2001 - 10/2000
3Hyperthermia
10/2001 - 03/2001

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
11/2019 - 02/2000
13CytokinesIBA
01/2020 - 09/2000
12Messenger RNA (mRNA)IBA
11/2017 - 01/2000
9Interleukin-8 (Interleukin 8)IBA
01/2008 - 04/2000
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2008 - 04/2000
7InterferonsIBA
05/2016 - 09/2000
7InterleukinsIBA
04/2009 - 06/2000
7Interleukin-6 (Interleukin 6)IBA
07/2008 - 01/2000
7Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2008 - 04/2000
7AntigensIBA
10/2007 - 08/2000
6AntibodiesIBA
01/2019 - 12/2000
6Monoclonal AntibodiesIBA
04/2004 - 07/2000
5Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2001
5Docetaxel (Taxotere)FDA Link
01/2021 - 01/2000
5Pharmaceutical PreparationsIBA
11/2019 - 04/2000
5Vehicle Emissions (Emissions, Vehicle)IBA
09/2016 - 07/2003
5PPAR gammaIBA
10/2009 - 04/2000
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2008 - 09/2000
5Matrix Metalloproteinases (MMPs)IBA
09/2001 - 04/2000
5Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
04/2001 - 05/2000
4Cisplatin (Platino)FDA LinkGeneric
01/2021 - 12/2000
4DNA (Deoxyribonucleic Acid)IBA
01/2020 - 03/2001
4Paclitaxel (Taxol)FDA LinkGeneric
07/2018 - 07/2000
4Chemotactic FactorsIBA
04/2009 - 01/2007
4Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2009 - 02/2000
41-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
04/2008 - 07/2003
4Doxorubicin (Adriamycin)FDA LinkGeneric
09/2001 - 12/2000
3AutoantibodiesIBA
01/2019 - 01/2005
3Indicators and Reagents (Reagents)IBA
01/2019 - 06/2000
3Biological ProductsIBA
11/2017 - 05/2000
3ChemokinesIBA
04/2009 - 10/2000
3NF-kappa B (NF-kB)IBA
04/2009 - 03/2000
3LipopolysaccharidesIBA
07/2008 - 07/2003
33-Iodobenzylguanidine (Iobenguane)IBA
07/2008 - 04/2006
3Estrogens (Estrogen)FDA Link
05/2007 - 11/2000
3Transforming Growth Factor beta (TGF-beta)IBA
02/2007 - 03/2000
3CollagenIBA
11/2005 - 02/2001
3Immunoglobulin G (IgG)IBA
01/2005 - 06/2001
3Capsaicin (Zostrix)FDA Link
06/2004 - 08/2000
3Serotonin (5 Hydroxytryptamine)IBA
09/2003 - 08/2001
3Interferon-alpha (Interferon Alfa)IBA
05/2003 - 07/2001
3Mitochondrial DNA (mtDNA)IBA
11/2001 - 10/2000
3beta-Galactosidase (Lactaid)IBA
09/2001 - 06/2000
3Methotrexate (Mexate)FDA LinkGeneric
09/2001 - 12/2000
3Phosphotransferases (Kinase)IBA
08/2001 - 01/2000
3Ion Channels (Ion Channel)IBA
08/2001 - 08/2000
3AndrogensIBA
08/2001 - 05/2000

Therapy/Procedure

33Therapeutics
01/2022 - 01/2000
20Drug Therapy (Chemotherapy)
01/2022 - 05/2000
10Radiotherapy
01/2021 - 03/2000
8Neoadjuvant Therapy
07/2018 - 01/2000
7Stents
08/2011 - 01/2001
7Gastrectomy
01/2003 - 03/2000
6Hepatectomy
09/2001 - 01/2000
5Lymph Node Excision (Lymph Node Dissection)
02/2012 - 05/2000
3Chemoradiotherapy
08/2022 - 04/2001
3Electrodes (Electrode)
09/2010 - 01/2000
3Brachytherapy
12/2001 - 07/2001
3Cystectomy
09/2001 - 12/2000